Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from PharmaTelevision

05:12 EDT 5th April 2020 | BioPortfolio

Here are the most relevant search results for "PharmaTelevision" found in our extensive news archives from over 250 global news sources.

More Information about PharmaTelevision on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PharmaTelevision for you to read. Along with our medical data and news we also list PharmaTelevision Clinical Trials, which are updated daily. BioPortfolio also has a large database of PharmaTelevision Companies for you to search.

Showing News Articles 1–25 of 1,300+ from PharmaTelevision

Monday 21st August 2017

Creating Living Therapeutics at the Royal Prince Alfred Hospital

Cell and Molecular Therapies (CMT), Royal Prince Alfred Hospital are committed to the development of novel cell therapies and the subsequent improvement in survival and quality of life of patients who’s needs are currently unmet. John Rasko chats about developing "living therapeutics" with Summer Parks of PharmaVentures at this years ISCT in London.

The importance of collaboration in Cellular Therapy

Professor Oscar Lee of the National Yang-Ming University discuss with Summer Park of PharmaVentures, the importance of collaboration in Cellular Therapy between Asia and the rest of the world. Filmed at ISCT 2017 in London.

Strimvelis, the Ex-vivo stem cell gene therapy to treat ADA-SCID

Children born with ADA-SCID do not develop a healthy immune system so cannot fight off everyday infections, which results in severe and life-threatening illness. Without prompt treatment, the disorder often proves fatal within the child’s first year of life. ADA-SCID is estimated to occur in approximately 15 patients per year in Europe. Emily Culme-Seymour of GSK talks to Summer Park about Strim...

Tuesday 15th August 2017

Prous Institute: Speeding up the drug discovery and development process

How much of a pharmaceutical candidate’s efficacy and safety can be predicted in silico, hence significantly speeding up the drug development process? Prous Institute for Biomedical Research is committed to discovering novel therapies for substantially unmet medical needs – namely oncology and CNS - by applying their expertise in computational science, synthetic chemistry, molecular and cellul...

Celyad: Directing a weaponised attack on cancer with NKR-T cell-based immunotherapy

Celyad focuses on translating promising research into transformative treatments aimed at reversing the outcome of severe diseases. Celyad identifies and further advances therapeutic solutions that have the potential to change the lives of thousands of patients worldwide. Georges Rawadi talks to Adrian Dawkes about how Celyad is using NK receptors to battle cancers.

PharmaVentures InSights interviews the International Society for Cellular Therapy

ISCT is a global association driving the translation of scientific research to deliver innovative cellular therapies to patients. ISCT is the only group focused on pre-clinical and translational aspects of developing cell therapy products. As such, ISCT helps academic, government and biotech/pharma sectors transform research into practise and product. Speaking at this years ISCT conference in Lond...

Cell Medica: Transforming patients live through cellular immunotherapy

Cell Medica is committed to transforming the treatment of cancer through the use of cellular immunotherapy. Through our internal development and collaborations and with leading academic research groups, we are working with three powerful technology platforms to generate safe and effective treatments to address a range of cancer types. Our goal is to develop curative cell-based therapies that ca...

Tuesday 14th March 2017

Will accelerated Laser PCR benefit time critical molecular tests?

Revolutionising the fundamentals of scientific and medical research. GNA Biosolutions is a Munich-based High-tech engineering firm which has developed instruments, OEM modules, and assays for ultra-fast, molecular pathogen detection - thanks to its proprietary, breakthrough technology. Federico Bürsgens the Managing Director of GNA Biosolutions discusses the story behind GNS Biosolutions with Adr...

How a collaborative approach is key to faster drug development

The centre of innovative medical discoveries. The Medicines Discovery Catapult is a new, national centre of applied R&D expertise to promote and support innovative, fast-to-patient drug discovery in the UK through collaborative projects across the community. MDC work with biopharma companies of all sizes, translational researchers, technology experts, patient groups and the contract research and f...

Are Medigene empowering T cells to effectively fight cancer?

Empowering patients on their fight against cancer. Medigene AG is a publicly listed (Frankfurt: MDG1, prime standard, TecDAX) biotechnology company headquartered in Martinsried near Munich, Germany. The company is developing highly innovative, complementary treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. Medigene concentrat...

iTeos Therapeutics: Combating cancer using immunotherapy against novel target combinations

iTeos Therapeutics is a spin-off from the Ludwig Cancer Research (LICR) and de Duve Institute (UCL). Focused on expanding the benefits of immunotherapy for cancer patients, the company is developing a proprietary pipeline targeting A2A, immune checkpoints and non-inflamed tumors. Adrian Dawkes speaks to Christophe Queva, CEO of iTeos Therapeutics.

Sunday 29th January 2017

RowAnalytics: Complex data integration and analytics software

RowAnalytics’ complex data integration and analytics software puts the power of real-time decision support and semantic search at your fingertips across mobile, smart, wearable and IoT devices

Thursday 26th January 2017

Atlantic Healthcare: Addressing the clinical needs of GI patients

Atlantic Healthcare plc is an emerging trans-Atlantic pharmaceutical group addressing the clinical needs of patients under specialist care, with an existing focus on gastrointestinal (GI) disease. Adrian Dawkes talks to Toby Wilson Waterworth, CEO about the companies aims to deliver on its commercialisation strategy through in-house product development, out-licensing of assets in non-core territo...

Karus Therapeutics: Developing best-in-class medicines to treat cancer

Karus is a leader in the design and development of innovative cancer therapies; these small-molecule drugs combine targeted therapy with immunotherapeutic activity for the effective treatment of a diverse range of tumors. Our approach has broad potential application in the treatment of hematological cancers and solid tumors.

BCF: A Different kind of practice

With more than 200 professionals working in 22 strategic multidisciplinary teams, BCF is the reference for everything connected to business law. Add to this its privileged relationships with highly respected law firms in cities around the globe as well as its membership in Meritas, one of the largest networks of independent law firms in the world, and you have the picture: we’re a spirited team,...

Sunday 22nd January 2017

Centauri Therapeutics: Focused on the discovery and development of novel molecules targeting life threatening diseases.

The Alphamer technology is based on "programmable immunity" in which chemically synthesised molecules redirect naturally occurring antibodies to selected pathogens to fight the infection. The molecules have two distinct parts: one end binds a cell-surface target on the pathogen using an aptamer whereas the other end presents specific epitopes that attach to the circulating antibodies. It has been ...

Thursday 19th January 2017

One Nucleus: The Business Catalyst for Life Science

One Nucleus is an international membership organisation for life science and healthcare companies. They are based in Cambridge with the majority of our members across the Cambridge/London corridor – at the heart of Europe’s largest life science and healthcare cluster. Harriet Fear CEO for One Nucleus discusses with Adrian Dawkes of PharmaVentures a range of subjects concerning business practic...

Sunday 15th January 2017

Newable: Helping to Start, Sustain, and Scale your business

Newable: 'We believe confidence transforms business. But like businesses, confidence needs to be built. In this section of our website you’ll find resources that may build up your confidence to take the next step with your business. How to guides, FAQ, white papers, case studies and of course the experiences of people like you and businesses like you. Ultimately though, our people are your best ...

Thursday 12th January 2017

Biotech and Money Investival 2016

Biotech and Money is an influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion dollar healthcare business. We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare.

GE Healthcare:

GE Healthcare (NYSE: GE) provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world.

Monday 9th January 2017

Green Bone: Biomimetic – Reabsorbable – Bamboo-derived bone graft scaffold

GREENBONE ORTHO SRL wants to become a worldwide leader for bone regeneration by providing innovative and easy to use bio-inspired solutions that will help cure severe diseases. The primary goal of GREENBONE is to develop a highly innovative bone implant, to generate biomimetic – reabsorbable – Bamboo-derived bone graft scaffold suitable to address non-union fractures and other very nasty skel...

Sunday 8th January 2017

Abpro: Creating novel, breakthrough medicines.

Abpro have streamlined all aspects of the process to create a state-of-the-art gene-to-antibody platform that allows rapid generation of antibodies against previously difficult targets. Applications include use in research, as diagnostics or as therapeutics. Our platform has been well proven and validated by major pharmaceutical, biotechnology and academic labs around the world.

Wednesday 4th January 2017

Mission Therapeutics: Yielding novel therapeutics for the benefit of patients

Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need. They have built a World-leading platform for the discovery and development of first-in-class, small-molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging, and hitherto intractable, drug class that ...

Cantargia: Development of new antibody-based cancer treatments

Cantargia specialises in antibody-based cancer treatment. CAN04, the company's patented antibody treatment, has a dual mechanism of action. CAN04 fights cancer by activating the immune system and blocking signals that lead to tumour growth. Treatment with CAN04 has the potential to become an important part of modern immuno-oncology.

Monday 2nd January 2017

Bone Therapeutics: A unique approach to the development of cell therapy products for bone fracture repair & fracture prevention.

Bone Therapeutics is a biotechnology company with a unique approach to the development of cell therapy products for bone fracture repair and fracture prevention. Bone Therapeutics is creating a new and unique treatment approach using differentiated bone-forming cells administered via a minimally invasive percutaneous procedure, that is expected to offer significant benefits over the current stand...


Quick Search

News Quicklinks